We are proud to be featured in such a nationally recognized publication as CenterWatch. See below for an exerpt from the August 31, 2010 CW Weekly publication. “Indiana now has its first commercial Institutional Review Board (IRB). Indiana and its...
Pearl IRB was featured in the August 21st weekly print publication and on the web. See below for an excerpt: “Before the first volunteer takes a needle in the arm to test an experimental drug, the proposed clinical trial must first be vetted by a panel of...
Many larger IRBs are under tremendous pressure to meet the demands of their clients. Some are taking on too many clients, too quickly, resulting in a stressful and rushed atmosphere. The clinical research environment has changed over the years. There is a steady...
Pearl IRB is pleased to launch it’s whitepaper entitled “Trends and Insights in IRB Warning Letters.” Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to...
August 2, 2010 Pearl IRB releases news about their role in fostering clinical trials in Indiana and beyond. Check out the full release, read a quote provided by Kristin Jones, President of Indiana Health Industry Forum and more. Read more.
